Zagoria R J, Dyer R B, Wolfman N T, Hinn G C, Chen Y M
Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC 27103.
Crit Rev Diagn Imaging. 1990;31(1):81-115.
Renal cell carcinoma (RCC), a potentially curable lesion, is the most common primary renal malignancy. Due to the importance of early diagnosis and the lack of specific clinical features of RCC, imaging plays a vital role in the diagnosis and management of RCC. Newer imaging modalities have superseded plain-film radiography in the diagnosis of RCC by offering greater sensitivity and specificity in both diagnosis and staging. RCC can be diagnosed with computed tomography (CT) with greater than 95% accuracy. Once an RCC is detected, tumor staging becomes paramount for treatment planning. Greater than 90% staging accuracy can be accomplished with CT alone using techniques described in this article. Magnetic resonance imaging (MRI) can be used to achieve staging accuracy similar to CT. MRI and ultrasonography (US) should be used to aid the diagnosis and staging of RCC in equivocal CT cases. The appropriate use of additional staging adjuncts including arteriography, phlebography, skeletal and thoracic imaging is described in this article.
肾细胞癌(RCC)是最常见的原发性肾脏恶性肿瘤,是一种有潜在治愈可能的病变。由于早期诊断的重要性以及肾细胞癌缺乏特异性临床特征,影像学检查在肾细胞癌的诊断和治疗中起着至关重要的作用。新型影像学检查方法在肾细胞癌的诊断中已取代了平片放射摄影,因为它们在诊断和分期方面都具有更高的敏感性和特异性。通过计算机断层扫描(CT)诊断肾细胞癌的准确率超过95%。一旦检测到肾细胞癌,肿瘤分期对于治疗方案的制定至关重要。仅使用本文所述技术,CT就能实现超过90%的分期准确率。磁共振成像(MRI)可用于实现与CT相似的分期准确率。在CT诊断不明确的肾细胞癌病例中,应使用MRI和超声检查(US)辅助诊断和分期。本文还介绍了包括动脉造影、静脉造影、骨骼和胸部成像等其他分期辅助手段的合理应用。